EARNEST Partners’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-4,400
| Closed | -$91K | – | 1175 |
|
|
2018
Q3 | $91K | Hold |
4,400
| – | – | ﹤0.01% | 270 |
|
|
2018
Q2 | $67K | Sell |
4,400
-31
| -0.7% | -$472 | ﹤0.01% | 282 |
|
|
2018
Q1 | $100K | Hold |
4,431
| – | – | ﹤0.01% | 266 |
|
|
2017
Q4 | $133K | Buy |
+4,431
| New | +$133K | ﹤0.01% | 244 |
|
|
2017
Q1 | – | Sell |
-4,431
| Closed | -$128K | – | 233 |
|
|
2016
Q4 | $128K | Buy |
4,431
+31
| +0.7% | +$896 | ﹤0.01% | 232 |
|
|
2016
Q3 | $140K | Hold |
4,400
| – | – | ﹤0.01% | 221 |
|
|
2016
Q2 | $143K | Hold |
4,400
| – | – | ﹤0.01% | 226 |
|
|
2016
Q1 | $123K | Hold |
4,400
| – | – | ﹤0.01% | 234 |
|
|
2015
Q4 | $157K | Hold |
4,400
| – | – | ﹤0.01% | 225 |
|
|
2015
Q3 | $146K | Hold |
4,400
| – | – | ﹤0.01% | 224 |
|
|
2015
Q2 | $184K | Hold |
4,400
| – | – | ﹤0.01% | 217 |
|
|
2015
Q1 | $143K | Hold |
4,400
| – | – | ﹤0.01% | 220 |
|
|
2014
Q4 | $140K | Hold |
4,400
| – | – | ﹤0.01% | 230 |
|
|
2014
Q3 | $109K | Hold |
4,400
| – | – | ﹤0.01% | 222 |
|
|
2014
Q2 | $99K | Hold |
4,400
| – | – | ﹤0.01% | 232 |
|
|
2014
Q1 | $107K | Sell |
4,400
-1,900
| -30% | -$46.2K | ﹤0.01% | 229 |
|
|
2013
Q4 | $157K | Buy |
+6,300
| New | +$157K | ﹤0.01% | 232 |
|